VOLITIONRX LTD Quarterly Debt-to-equity in % from Q3 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Volitionrx Ltd quarterly Debt-to-equity history and growth rate from Q3 2012 to Q3 2024.
  • Volitionrx Ltd Debt-to-equity for the quarter ending September 30, 2024 was -216 %, a 97.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -216 +7.51K +97.2% Sep 30, 2024
Q2 2024 -274 -2.54K -112% Jun 30, 2024
Q1 2024 -592 -4.74K -114% Mar 31, 2024
Q4 2023 -1.59K -2.14K -391% Dec 31, 2023
Q3 2023 -7.73K -7.93K -3937% Sep 30, 2023
Q2 2023 2.26K +2.15K +1938% Jun 30, 2023
Q1 2023 4.14K +4.08K +6480% Mar 31, 2023
Q4 2022 548 +510 +1350% Dec 31, 2022
Q3 2022 201 +163 +424% Sep 30, 2022
Q2 2022 111 +73.5 +196% Jun 30, 2022
Q1 2022 63 +23.1 +58% Mar 31, 2022
Q4 2021 37.8 -13.3 -26% Dec 31, 2021
Q3 2021 38.5 -9.88 -20.4% Sep 30, 2021
Q2 2021 37.6 -9.8 -20.7% Jun 30, 2021
Q1 2021 39.9 -7.48 -15.8% Mar 31, 2021
Q4 2020 51.1 +11.6 +29.4% Dec 31, 2020
Q3 2020 48.3 +10.4 +27.2% Sep 30, 2020
Q2 2020 47.4 +8.24 +21.1% Jun 30, 2020
Q1 2020 47.3 +3.98 +9.18% Mar 31, 2020
Q4 2019 39.5 -3.7 -8.56% Dec 31, 2019
Q3 2019 38 -5.75 -13.1% Sep 30, 2019
Q2 2019 39.1 -4.86 -11.1% Jun 30, 2019
Q1 2019 43.4 +8.17 +23.2% Mar 31, 2019
Q4 2018 43.2 +12.3 +39.8% Dec 31, 2018
Q3 2018 43.7 +19.4 +79.8% Sep 30, 2018
Q2 2018 44 +22.7 +107% Jun 30, 2018
Q1 2018 35.2 +16.8 +91.3% Mar 31, 2018
Q4 2017 30.9 +15.2 +97.3% Dec 31, 2017
Q3 2017 24.3 +7.69 +46.2% Sep 30, 2017
Q2 2017 21.3 +4.57 +27.4% Jun 30, 2017
Q1 2017 18.4 -0.09 -0.49% Mar 31, 2017
Q4 2016 15.7 -3.9 -19.9% Dec 31, 2016
Q3 2016 16.6 -11.9 -41.7% Sep 30, 2016
Q2 2016 16.7 -68.1 -80.3% Jun 30, 2016
Q1 2016 18.5 -215 -92.1% Mar 31, 2016
Q4 2015 19.6 +361 Dec 31, 2015
Q3 2015 28.5 +359 Sep 30, 2015
Q2 2015 84.8 +1.19K Jun 30, 2015
Q1 2015 233 -12.3K -98.1% Mar 31, 2015
Q4 2014 -341 -613 -226% Dec 31, 2014
Q3 2014 -330 -585 -229% Sep 30, 2014
Q2 2014 -1.11K -1.28K -729% Jun 30, 2014
Q1 2014 12.5K +12.4K +9407% Mar 31, 2014
Q4 2013 271 +157 +138% Dec 31, 2013
Q3 2013 255 +153 +149% Sep 30, 2013
Q2 2013 176 Jun 30, 2013
Q1 2013 131 Mar 31, 2013
Q4 2012 114 Dec 31, 2012
Q3 2012 102 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.